These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30409280)

  • 1. The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go?
    Holmes DR; Hance R; Syrek Jensen TS; Schwartz DA; Kaplan A; Farb A; Zuckerman B; Leon M; Waklowiak J; Mack MJ; Shuren J
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2220-2225. PubMed ID: 30409280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review.
    Holmes DR; Farb AA; Chip Hance R; Leon MB; Goldberg P; Zuckerman BD; Kaplan AV; Rincon-Gonzalez L; Hunt J; Walkowiak J; Mack MJ
    J Am Coll Cardiol; 2020 Dec; 76(23):2786-2794. PubMed ID: 33272373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical device development ecosystem: Current regulatory state and challenges for future development: A review.
    Holmes DR; Farb A; Dib N; Jacques L; Rowe S; DeMaria A; King S; Zuckerman B
    Cardiovasc Revasc Med; 2024 Mar; 60():95-101. PubMed ID: 37778922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory strategies for early device development and approval.
    Holmes DR; Geoffrion R; Hunt J; Hance RC; Leon MB; Mack MJ; Kaplan AV
    Catheter Cardiovasc Interv; 2022 May; 99(6):1784-1788. PubMed ID: 35485732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US 21st Century Cures Act secures health-care research funding.
    Furlow B
    Lancet Oncol; 2017 Jan; 18(1):24. PubMed ID: 27979600
    [No Abstract]   [Full Text] [Related]  

  • 6. The 21st century cures act: Opportunities and challenges.
    Sarpatwari A; Kesselheim AS
    Clin Pharmacol Ther; 2015 Dec; 98(6):575-7. PubMed ID: 26264909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough Medical Devices and the 21st Century Cures Act.
    Kesselheim AS; Hwang TJ
    Ann Intern Med; 2016 Apr; 164(7):500-2. PubMed ID: 26785350
    [No Abstract]   [Full Text] [Related]  

  • 9. The Medical Device Innovation Consortium and Its Goal to Further the Efficiency of Early Feasibility Studies in the United States.
    Holmes DR; Mack MJ; Leon M; Kaplan AV; Hance RC
    J Endovasc Ther; 2019 Jun; 26(3):423-424. PubMed ID: 31106689
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Perspective--Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory Reform.
    Holmes DR; Shuren J; Califf R; Zuckerman B; Abel D; Farb A; Leon M; Mack M
    JACC Cardiovasc Interv; 2016 Mar; 9(6):626-8. PubMed ID: 27013168
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of health-related technologies in Germany.
    Perleth M; Busse R; Schwartz FW
    Health Policy; 1999 Jan; 46(2):105-26. PubMed ID: 10346284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and Device Development: Tips for Optimizing Your Experience With the Food and Drug Administration.
    Brooks SS
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):109-115. PubMed ID: 28673647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 21st Century Cures Act: can the regulatory framework survive the "cures"?
    Osorio-de-Castro CG; Caetano R; Pepe VL
    Cad Saude Publica; 2015 Sep; 31(9):1807-10. PubMed ID: 26578005
    [No Abstract]   [Full Text] [Related]  

  • 14. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences.
    Tsoi B; Masucci L; Campbell K; Drummond M; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):497-511. PubMed ID: 23977976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liability, regulation and policy in surgical innovation: the cutting edge of research and therapy.
    Mastroianni AC
    Health Matrix Clevel; 2006; 16(2):351-442. PubMed ID: 16948248
    [No Abstract]   [Full Text] [Related]  

  • 17. The 21st Century Cures Act--Will It Take Us Back in Time?
    Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jun; 372(26):2473-5. PubMed ID: 26039522
    [No Abstract]   [Full Text] [Related]  

  • 18. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress Considers Legislation on "21st Century Cures".
    Consult Pharm; 2015 Jul; 30(7):424. PubMed ID: 26173195
    [No Abstract]   [Full Text] [Related]  

  • 20. Working with the Food and Drug Administration's Center for Devices to Advance Regulatory Science and Medical Device Innovation.
    Malinauskas RA; Saha A; Sheldon MI
    Artif Organs; 2015 Apr; 39(4):293-9. PubMed ID: 25850595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.